| abstract |
The present invention relates to a pharmaceutical composition comprising, as active principle, a compound of formula: (CF DRAWING IN BOPI) in which the groups A and B are chosen independently of one another from: - a mono aryl group -, bi- or tricyclic having from 6 to 14 carbon atoms; - a heteroaromatic group chosen from pyridyl, pyrimidyl, pyrrolyl, furyl and thienyl groups; - an alkyl group having from 1 to 14 carbon atoms; - a cycloalkyl group having 5 to 8 carbon atoms; a saturated heterocyclic group chosen from tetrahydrofuryl, tetrahydropyrranyl, piperidinyl and pyrrolidinyl groups; its solvate or a salt of this acid with a pharmaceutically acceptable base. |